Here are relevant reports on : artificial-intelligence-in-drug-discovery-market
-
Single-molecule Real-time (SMRT) Sequencing Market by Offering (Products, Services), Workflow (Sequencing, Data Analysis), Application (Drug Discovery, Diagnostic, Agriculture), End User (Academia, Pharma, Biotech) - Forecast to 2030
The Single-molecule Real-time (SMRT) Sequencing Market, valued at US$2.83 billion in 2024, stood at US$2.92 billion in 2025 and is projected to advance at a resilient CAGR of 12.8% from 2025 to 2030, culminating in a forecasted valuation of US$5.32 billion by the end of the period. This market is expanding as long-read sequencing is used more often in rare disease diagnostics, cancer genomics, and broader precision medicine programs.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Immune Repertoire Sequencing Market by Product (Instrument, Software, Assay Kit & Reagent (TCR, BCR Kit)), Technology (Sequencing, Bioinformatics), Service (Data Analysis), Application (Research, Drug Discovery & Development) - Global Forecast to 2030
Global immune repertoire sequencing market valued at $344.2M in 2024, reached $354.6M in 2025, and is projected to grow at a robust 9.6% CAGR, hitting $560.5M by 2030. The growth of the Asia Pacific IRS market is primarily due to growing R&D investments and the increasing presence of major industry stakeholders in the region.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
AI in Precision Medicine Market by Application (Drug Discovery, Screening, Diagnosis, Stratification, Staging, Prognosis, Therapy Selection, Monitoring, Risk Management), Indication (Cancer, CNS, CVS), Tools (ML, NLP), & End User -Global Forecast to 2030
The global AI in Precision Medicine market, valued at US$0.60 billion in 2023, stood at US$0.78 billion in 2024 and is projected to advance at a resilient CAGR of 30.7% from 2024 to 2030, culminating in a forecasted valuation of US$3.92 billion by the end of the period. Growth in precision medicine, AI’s efficiency in drug discovery, integration of Real-World Evidence (RWE) in emerging markets to drive the market significantly.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & Development, Clinical Diagnostics), End User & Region - Global Forecast to 2029
The global gene expression analysis market, valued at US$3.9 billion in 2023, stood at US$4.2 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$6.2 billion by the end of the period. Growth in this market is primarily driven by the increasing investments by pharmaceutical & biotechnology companies for genome based studies.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
APAC Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics (IHC, ISH), Spatial Genomics (FISH, Sequencing)), Product (Instruments, Consumables, Software), Application (Drug Discovery), End User (Biotech, CROs) - Forecast to 2027
The global APAC spatial genomics & transcriptomics market, stood at US$64 million in 2022 and is projected to advance at a resilient CAGR of 18.9% from 2023 to 2027, culminating in a forecasted valuation of US$152 million by the end of the period.
- Published: January 2023
- Price: $ 4950
- TOC Available:
-
Asia Pacific Proteomics Market by Instrumentation [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery) - Forecast to 2030
The Asia Pacific Proteomics Market, valued at USD 7.82 billion in 2024, stood at USD 8.57 billion in 2025 and is projected to advance at a resilient CAGR of 14.1% from 2025 to 2030, culminating in a forecasted valuation of USD 16.61 billion by the end of the period. Proteomics focuses on measuring dynamic protein expression, modifications, and interactions at scale, enabling deeper insights into disease biology and treatment response for oncology, neurology, and other complex indications.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Liquid Handling System Market by Type (Automated, Electronic, Manual), Product (Pipettes, Consumables, Accessories, Software), Application (Drug Discovery, Genomics, Diagnostics, Proteomics, Food, Forensic, Environmental), End User, Region - Global Forecasts to 2030
The global liquid handling systems market, valued at US$4.7B in 2024, is forecasted to grow at a 8.0% CAGR, reaching US$ 5.1B by 2025 and US$7.4B by 2030. The increasing trend of outsourcing pharmaceutical research enables businesses to cut costs and obtain specialty expertise. Rising investments in life sciences research and development are helping fuel innovation across the drug discovery and development process.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Antigen & Antibodies Market by Product (Antigens, ABs), Technique (ELISA, CLIA, IHS, IFA), Application (Diagnosis, Drug Discovery, Research), Healthcare Provider Facilities (ASCs & Clinics, Labs, Biotech& Pharma Companies) - Global Forecast to 2027
The global Antigen and Antibodies Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the advancing proteomics and genomics research, massive use of antigen and antibodies in the vaccine development, drug discovery, disease study and diagnosis.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Protein Microarrays Market by Offering (Products, Services), Type (Biochips, Microarray Instruments), Application (Clinical, Drug Discovery) - Global Forecast to 2030
The global protein microarrays market, valued at US$0.93 billion in 2024, stood at US$1.00 billion in 2025 and is projected to advance at a resilient CAGR of 12.3% from 2025 to 2030, culminating in a forecasted valuation of US$1.78 billion by the end of the period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Base Editing Market by Product (Platform, Reagents & Kits, Plasmids), Service (gRNA Design, Cell Line Engineering), Type, Targeted base (Cytosine, Adenine), Application (Drug Discovery, Agriculture, Veterinary), and Region - Global Forecast to 2028
The global base editing market, valued at US$260 million in 2022, stood at US$270 million in 2023 and is projected to advance at a resilient CAGR of 15.2% from 2023 to 2028, culminating in a forecasted valuation of US$549 million by the end of the period.The growth of the base editing market is largely driven by the rising prevalence of genetic diseases, and the increasing recognition of the role of genetic mutations in various diseases has fueled the demand for precise gene editing technologies.
- Published: December 2023
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
